"Piperazines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D010879
|
MeSH Number(s) |
D03.383.606
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Piperazines".
Below are MeSH descriptors whose meaning is more specific than "Piperazines".
This graph shows the total number of publications written about "Piperazines" by people in this website by year, and whether "Piperazines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2007 | 4 | 0 | 4 |
2008 | 2 | 2 | 4 |
2009 | 4 | 0 | 4 |
2010 | 2 | 1 | 3 |
2011 | 2 | 0 | 2 |
2012 | 1 | 2 | 3 |
2013 | 1 | 4 | 5 |
2014 | 2 | 0 | 2 |
2015 | 1 | 2 | 3 |
2016 | 1 | 3 | 4 |
2017 | 24 | 40 | 64 |
2018 | 21 | 46 | 67 |
2019 | 4 | 25 | 29 |
2020 | 1 | 2 | 3 |
2021 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Piperazines" by people in Profiles.
-
SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells. J Virol. 2021 08 10; 95(17):e0079421.
-
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients. J Med Virol. 2021 12; 93(12):6557-6565.
-
Recent advances in drug repurposing using machine learning. Curr Opin Chem Biol. 2021 12; 65:74-84.
-
CROI 2021: Advances in Antiretroviral Therapy for HIV and Antiviral Therapy for COVID-19. Top Antivir Med. 2021 Jun-Jul; 29(3):361-378.
-
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV. 2021 06; 8(6):e317-e318.
-
Resuscitative Effect of Centhaquine (Lyfaquin®) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial. Adv Ther. 2021 06; 38(6):3223-3265.
-
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells. ACS Chem Biol. 2021 04 16; 16(4):642-650.
-
Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study. Molecules. 2021 Mar 17; 26(6).
-
Risk-adapted adjuvant therapy of luminal early breast cancer in 2020. Curr Opin Obstet Gynecol. 2021 02 01; 33(1):53-58.
-
COVID-19 infection in Hokkaido, Japan might depend on the viscosity of atmospheric air. Virus Res. 2021 02; 293:198259.